Heering P, Kutkuhn B, Frenzel H, Linke R P, Grabensee B
Department of Nephrology, University of Medicine, Düsseldorf, FRG.
Int Urol Nephrol. 1989;21(3):339-47. doi: 10.1007/BF02559746.
Renal transplantation was performed in 2 patients with end-stage renal disease due to AA-type amyloidosis. One patient with amyloidosis of rheumatoid arthritis (RA) origin died twelve months after renal transplantation in cardiogenic shock. AA-amyloid deposits were demonstrated in the graft even though there were excellent function and no proteinuria. The second patient with amyloid nephropathy due to familial Mediterranean fever (FMF) showed no impairment of graft function 24 months after transplantation. These 2 cases are compared to an additional 31 cases of renal transplantation for amyloid nephropathy described in the literature. Proteinuria was reported in 32.3% and amyloid was detected in the functioning graft in 41.4%. The function was excellent even when small amyloid deposits were present in the graft. Renal transplantation is indicated in cases of amyloid nephropathy of the AA-type, provided life threatening amyloid involvement of other organs is not present.
对2例因AA型淀粉样变性导致终末期肾病的患者进行了肾移植。1例类风湿关节炎(RA)源性淀粉样变性患者在肾移植后12个月死于心源性休克。尽管移植肾功能良好且无蛋白尿,但在移植物中仍发现了AA淀粉样沉积物。第2例因家族性地中海热(FMF)导致淀粉样肾病的患者在移植后24个月移植物功能未受损。将这2例病例与文献中描述的另外31例淀粉样肾病肾移植病例进行了比较。报告蛋白尿的发生率为32.3%,在功能正常的移植物中检测到淀粉样蛋白的发生率为41.4%。即使移植物中存在少量淀粉样沉积物,功能仍良好。如果不存在威胁生命的其他器官淀粉样蛋白累及情况,AA型淀粉样肾病病例适合进行肾移植。